The chemistry of heparin.
作者信息
Jorpes E
机构信息
The Physiological Chemistry Department of the Caroline Institute, Stockholm, and the Insulin Laboratory of the Vitrum Company, Stockholm.
出版信息
Biochem J. 1935 Aug;29(8):1817-30. doi: 10.1042/bj0291817.
Abstract
摘要
相似文献
1
The chemistry of heparin.肝素的化学性质。
Biochem J. 1935 Aug;29(8):1817-30. doi: 10.1042/bj0291817.
2
[Contribution to the analytical chemistry of heparin. IV. Indirect polarographic evaluation of heparin].[肝素的分析化学研究。IV. 肝素的间接极谱法测定]
Cesk Farm. 1966 Jun;15(5):260-1.
3
THE DISAPPEARANCE OF HEPARIN ACTIVITY WITH LIVER GLOBULINS AND DETERMINATIONS OF HEPARINASE.肝素活性与肝球蛋白的消失及肝素酶的测定
Thromb Diath Haemorrh. 1963 Nov 1;10:71-80.
4
Chemistry of heparin and low molecular weight heparin.肝素与低分子量肝素的化学性质
Acta Chir Scand Suppl. 1988;543:52-6.
5
[Pharmacology of heparin].[肝素的药理学]
Z Gesamte Inn Med. 1979 Jan 1;34(1):3-8.
6
[ON THE MECHANISM OF THE INTERACTION OF HEPARIN WITH ANTIBIOTICS].[关于肝素与抗生素相互作用的机制]
Biokhimiia. 1964 Jul-Aug;29:831-6.
7
Heparin: biochemistry, therapy, and laboratory monitoring.肝素：生物化学、治疗及实验室监测
Ther Drug Monit. 1979;1(2):173-97.
8
Chemistry of heparin. A short review on recent chemical trends.肝素的化学。近期化学趋势的简要综述。
Thromb Diath Haemorrh. 1975 Feb 28;33(1):20-5.
9
[Some peculiarities of trypsin and heparin interaction].[胰蛋白酶与肝素相互作用的一些特性]
Biokhimiia. 1978 Oct;43(10):1924-8.
10
[Study in vitro concerning the mechanism of the neutralization of heparin by its antagonists].[肝素拮抗剂中和肝素机制的体外研究]
Hemostase. 1966 Jan-Mar;6(1):25-39.
引用本文的文献
1
Anticoagulation in Acute Stroke: Early Claims and Later Doubts.急性卒中的抗凝治疗：早期的主张与后来的质疑
Neurocrit Care. 2024 Nov 12. doi: 10.1007/s12028-024-02160-6.
2
Current Perspectives on Diagnostic Assays and Anti-PF4 Antibodies for the Diagnosis of Heparin-Induced Thrombocytopenia.肝素诱导的血小板减少症诊断中诊断检测及抗PF4抗体的当前观点
J Blood Med. 2020 Aug 17;11:267-277. doi: 10.2147/JBM.S232648. eCollection 2020.
3
Circulating N-Linked Glycoprotein Side-Chain Biomarker, Rosuvastatin Therapy, and Incident Cardiovascular Disease: An Analysis From the JUPITER Trial.循环N-连接糖蛋白侧链生物标志物、瑞舒伐他汀治疗与心血管疾病事件：来自JUPITER试验的分析
J Am Heart Assoc. 2016 Jul 13;5(7):e003822. doi: 10.1161/JAHA.116.003822.
4
Measuring anti-factor xa activity to monitor low-molecular-weight heparin in obesity: a critical review.测量抗Xa因子活性以监测肥胖患者的低分子量肝素：一项批判性综述。
Can J Hosp Pharm. 2015 Jan-Feb;68(1):33-47. doi: 10.4212/cjhp.v68i1.1423.
5
Mast cell function: a new vision of an old cell.肥大细胞功能：对一种古老细胞的新认识。
J Histochem Cytochem. 2014 Oct;62(10):698-738. doi: 10.1369/0022155414545334. Epub 2014 Jul 25.
6
The structural basis for a coordinated reaction catalyzed by a bifunctional glycosyltransferase in chondroitin biosynthesis.一个双功能糖基转移酶在软骨素生物合成中催化的协调反应的结构基础。
J Biol Chem. 2012 Oct 19;287(43):36022-8. doi: 10.1074/jbc.M112.375873. Epub 2012 Aug 30.
7
Analysis and characterization of heparin impurities.肝素杂质的分析与特性描述。
Anal Bioanal Chem. 2011 Jan;399(2):527-39. doi: 10.1007/s00216-010-4121-x. Epub 2010 Sep 3.
8
A CONSIDERATION OF RECENT ADVANCES IN MEDICAL SCIENCE IN THE LIGHT OF LORD LISTER'S STUDIES.从李斯特勋爵的研究看医学科学的近期进展
Can Med Assoc J. 1939 Oct;41(4):323-31.
9
The prevention and treatment of venous thromboembolism with LMWHs and new anticoagulants.低分子量肝素和新型抗凝剂在静脉血栓栓塞症的预防与治疗中的应用
Vasc Health Risk Manag. 2009;5:693-704. doi: 10.2147/vhrm.s4621. Epub 2009 Aug 20.
10
Heparin and Thrombosis: Harvey Lecture, November 28, 1940.肝素与血栓形成：哈维讲座，1940年11月28日
Bull N Y Acad Med. 1941 Oct;17(10):796-817.
本文引用的文献
1
A colorimetric method for the determination of glucosamine and chondrosamine.一种用于测定氨基葡萄糖和软骨糖胺的比色法。
Biochem J. 1933;27(6):1824-8. doi: 10.1042/bj0271824.
Zotero 插件